Shanta Chawla, M.D. has been appointed vice president of Clinical Development at CytRx Corp. Dr. Chawla has more than 13 years of clinical research, operations, and development experience, with a focus on oncology.   Dr. Chawla joins the company from Spectrum Pharmaceuticals, most recently serving as vice president of Clinical R&D, where she selected clinical trial sites and principal investigators, established protocols with the FDA, and prepared FDA filings.   “In this new position, Dr. Ch...